SkinHealth Systems (SKIN) Cash from Investing Activities (2020 - 2026)

SkinHealth Systems (SKIN) has reported Cash from Investing Activities for 7 consecutive years, with -$1.2 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash from Investing Activities rose 22.36% year-over-year to -$1.2 million in Q2 2026; TTM through Jun 2026 was -$5.3 million, a 5.86% increase from a year earlier, with the FY2025 full-year figure at -$5.2 million, up 24.01% from the prior year.
• Cash from Investing Activities was -$1.2 million for Q2 2026 at SkinHealth Systems, up from -$1.6 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$862000.0 in Q4 2024 and troughed at -$21.7 million in Q1 2023.
• A 5-year average of -$3.6 million and a median of -$2.1 million in 2024 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities plunged 533.11% in 2023 and jumped 91.69% in 2024, its largest moves.
• Over 5 years, Cash from Investing Activities stood at -$2.8 million in 2022, then increased by 23.23% to -$2.2 million in 2023, then jumped by 60.24% to -$862000.0 in 2024, then plunged by 60.32% to -$1.4 million in 2025, then grew by 12.81% to -$1.2 million in 2026.
• The last three Cash from Investing Activities figures came in at -$1.2 million (Q2 2026), -$1.6 million (Q1 2026), and -$1.4 million (Q4 2025), per Business Quant data.